Impact of preoperative levels of hemoglobin and albumin on the survival of pancreatic carcinoma;Impacto de los niveles preoperatorios de hemoglobina y albúmina en la supervivencia del carcinoma de páncreas

Revista Espanola de Enfermedades Digestivas

Volumn 102, Issue 11, 2010, Pages 631-636

  Ruiz Tovar, J ^a   Martin Perez E ^b   Fernandez Contreras M E ^c,d   Reguero Callejas Y, M E ^e   Gamallo Amat, C ^c  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b Servicio de Cirugía General y del Aparato Digestivo   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Albumina; Hemoglobin; Pancreatic cancer; Prognostic factors; Survival

Indexed keywords

ALBUMIN; HEMOGLOBIN; SERUM ALBUMIN;

ARTICLE; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

EID: 79251529896     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082010001100003     Document Type: Article

References (21)

1. Gawron AJ, Gapstur SM, Fought AJ, et al. Sociodemographic and tumour characteristics associated with pancreatic cancer surgery in the United States. J Surg Oncol 2008; 97: 578-82.
2. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 2003; 237: 74-85.
3. Garcia Borobia FJ, Jorba Martin R, Fabregat Prous J. Adenocarcinoma de pancreas y del área periampular. En: Cirugía AEC. Manual de la Asociación Española de Cirujanos. Madrid: Panamericana, 2005: 573-84.
4. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30.
5. Friess H, Ko CK, Kleeff J, et al. Pancreaticoduodenectomy, distal pancreatectomy, segmental pancretectomy, total pancretectomy and transduodenal resection of the papilla of Vater. En: Blumgart LH. Surgery of the liver, biliary tract and pancreas. Philadelphia: Saunders, 2007: 877-903.
6. Morganti AG, Forni F, Macchia G, et al. Chemoradiation of unresectable pancreatic carcinoma: Impact o pre-treatment haemoglobin levels on patterns of failure. Strahlenther Onkol 2003; 179: 87-92.
7. Schäfer U, Micke O, Müller SB, et al. Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors. Strahlenther Onkol 2003; 179: 527-34.
8. Valencia Juive J, Alonso Orduña V, Esco Baron R, et al. Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy. Clin Trans Oncol 2006; 8: 22-30.
9. Grogan M, Thomas GM, Melamed I, et al. Important of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999; 86: 1528-36.
10. Pollack A, Zagars GK, Dinney CP, et al. Preoperative radiotherapy for muscle- invasive bladder carcinoma. Long term follow-up and prognotic factors for 338 patients. Cancer 1994; 74: 2819-27.
11. Reichel O, Panzer M, Wimmer C, et al. Prognostic implications of haemoglobin levels before and after surgery as well as before and after chemotherapy for head and neck tumours. Eur Arch Otorhinolaryngol 2003; 260: 248-53.
12. Kong AC, Mehta V, Le QT, et al. Pancreatic tumor show high levels of hypoxia. Int J Radiat Oncol Biol Phys 2000; 48: 919-22.
13. Molls M, Stadler P, Becker A, et al. Revelance of oxygen in radiation oncology. Strahlenthera Onkol 1998; 174: 13-6.
14. Dunst J, Pigorsch S,Hansen G, et al. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia estimulate angiogenesis? Strahlenther Onkol 1999; 175: 93-6.
15. Brizel DM, Scully SP, Harrelson JM, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996; 56: 941-3.
16. Sweeney PJ, Nicolae D, Igncion L, et al Effects of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: Final report of a randomized, open-labelled, phase II trial. Br J Cancer 1998; 77: 1996-2002.
17. Gibbs J, Cull W, Henderson W, et al. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 1999; 134: 36-42.
18. Sirott MN, Bajorin DF, Wong GY, et al. Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis. Cancer 1993; 72; 3091-8.
19. McMillan DC, Watson WS, O'Gorman P, et al. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 2001; 39: 210-3.
20. Siddiqui A, Heinzerling J, Livingston EH, et al. Predictors of early mortality in veteran patients with pancreatic cancer. Am J Surg 2007; 194: 362-6.
21. Schmid I, Schmitt M, Streiter M, et al. Effects of soluble TNF receptor II (sTNF-RII), IL-1 receptor antagonist (IL-1ra), tumor load and hypermetabolism on malnutrition in children with acute leukaemia. Eur J Med Res 2005; 10:457-61.